Patients with refractory Crohn’s disease who previously received ustekinumab experienced clinical and endoscopic improvements ...

The treatment of relapsed/refractory multiple myeloma dramatically changed in recent years with the emergence of therapies ...

In the phase 2 expansion cohorts, patients with melanoma will receive imneskibart plus aldesleukin (RP2D), with the addition ...

Patients with refractory chronic cough who received twice-daily Haduvio for 21 days had decreases in cough frequency and ...

Hundreds more people with an aggressive form of blood cancer can now be offered hope of a cure and “a new lease of life” from today thanks to an NHS drug rollout.

Refractory hydrocephalus (RH) refers to cases of fluid buildup in the brain that resist standard treatment, leading to ...

Unprecedented Phase 1 CML efficacy data with 64% MMR achievement by 24 weeks in a refractory patient populationEncouraging safety and ...

Paraneoplastic Syndrome, Lung Neoplasia, Electrolyte Imbalance, Geriatric Oncology, Palliative Care Share and Cite: Ramos, F.

The U.S. Food and Drug Administration (FDA) has granted a regenerative medicine advanced therapy designation to MB-105, a CD5 ...

Kura Oncology will host a conference call on November 13, 2025, at 12:30 pm ET / 9:30 am PT – SAN DIEGO and TOYKO, Nov. 13, ...

Two phase 3 trials will study Kura Oncology’s ziftomenib for frontline acute myeloid leukemia, one with venetoclax and the ...

The treatment landscape for systemic lupus erythematosus (SLE) has shifted greatly in recent years, driven by the emergence ...